AI Drug Discovery: Which Pharma Companies are Leading this Revolution?
In recent years, we’ve witnessed a rapid surge of investment towards the use of artificial intelligence (AI) in speeding up drug discovery and upping the success rates of pharmaceuticals research. Our aging population is just ... [Read]
Pharmaceutical Stocks to Watch: Jazz, Viking, and CRISPR
Pharmaceutical stocks are seeing major movement in the market today, with the spotlight shining on CRISPR Therapeutics AG (NASDAQ:CRSP), Viking Therapeutics Inc. (NASDAQ:VKTX), and Jazz Pharmaceuticals (NASDAQ:JAZZ). Pharmaceutical Stocks to Watch: Viking Therapeutics Viking Therapeutics Inc. received ... [Read]
Sonoma Pharmaceuticals FDA Approval – Shares Soar
California-based Sonoma Pharmaceuticals (Nasdaq:SNOA) has received approval from the US Food and Drug Administration (FDA) for their antimicrobial post-therapy gel. Shares of the company soared this morning after the announcement and, currently, the high for ... [Read]
Top Biopharm Stocks Today: Here’s What Investors Should Know
As usual, biopharm stocks dominate the top of the small-cap stock gainers list today. Yahoo Finance Vericel (NASDAQ:VCEL) Share price: $11.15 | 24h change: 15.54% | 52-week change: 312.9% | Market cap: $412.6M Vericel ... [Read]
Dermira Stocks Plummet Over -65% Over Drug Failure
Stocks in Biopharmaceutical company Dermira have plummeted nearly -65% over the weekend on reports that its acne drug olumacostat glasaretil has failed it’s Phase 3 trials. In a news release, Dermira announced that the drug, ... [Read]
Best Pharma Stocks Today: Cascadian Therapeutics Up Over 70%
Looking for the best pharma stocks to invest in today? One of the biggest gainers by far is Cascadian Therapeutics, which, with a current share price of $10.09 USD, has been soaring with a 24-hour ... [Read]
Achaogen Stock Climbing After Positive Trial Outcome
Share prices in late-stage biopharmaceutical company Achaogen (NASDAQ:AKAO) Inc. took a sharp rise today on the heels of news that the FDA positively inspected a manufacturing plant associated with the production of its drug plazomicin. ... [Read]
New Strong Buy Stocks for December 14th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increased more than ... [Read]
Why Sangamo Therapeutics (SGMO) Could Be Positioned for a Surge
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is a clinical-stage biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the ... [Read]
A Look at Anavex Life Sciences Corp.’s Current Standings
Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The company’s lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX2-73 with donepezil, ANAVEX 19-144, ANAVEX ... [Read]